Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy of Botulinum Toxin Type A in the Treatment of Sialorrhea in the Patient Affected by Amyotrophic Lateral Sclerosis (ALS)

NCT01551940 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT01551940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01551940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy of Botulinum Toxin Type A in the Treatment of Sialorrhea in the Patient Affected by Amyotrophic Lateral Sclerosis (ALS)
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
March 31, 2014
Enrollment
18 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, sialorrhea